Page 6 - Eric Simpson News Today

NEW ORLEANS — Patients with hand and foot atopic dermatitis experienced significant improvement with dupilumab, which sustained an acceptable safety profile, according to phase 3 study results presented here. “These results are the first to highlight how Dupixent can improve signs and symptoms of atopic hand and foot dermatitis, which is very difficult to treat,” Eric Simpson,

/PRNewswire/ -- Kyowa Kirin Co., Ltd. (TSE: 4151) today announces that data from the Phase 2b study of rocatinlimab (KHK4083/AMG 451), an investigational...

OHSU researchers have worked to reduce barriers such as language and lack of transportation to increase participation.

Hartleys new Fellrunners beer had people scampering back to the bar for more in 1988.

The results of pooled safety data for Adbry showed positive effects in the prolonged treatment of moderate to severe atopic dermatitis, according to a study. Adbry (tralokinumab, LEO Pharma) is the only FDA-approved biologic that specifically binds to and inhibits the interleukin (IL)-13 cytokine, one of the drivers of atopic dermatitis.

Did we use the wrong emollients, or did we start it too late? Or should we start facing the possibility that maybe emollients really do not prevent eczema? the studys senior investigator asked.

West Texas has options for students to enjoy this fall. Farmers Market, T&J Farms and At’l Do Farms are great fall date ideas for students.

At’l Do Farms changes its corn maze from corn to a variety of other crops due to lack of water. These crops replicate corn stalks so visitors can continue to

You’ve broken out in a red, itchy rash. You’re likely wondering where it came from—and, most importantly, how ...

Fourteen environmental justice organizations from around the United States have begun to receive money under the Justice40 initiative, a business accelerator announced Wednesday. The Justice40 Acceler...